Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

Similar articles for PubMed (Select 21830014)

1.

Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer.

Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, Marotti J, Connolly JL, Schnitt SJ, Collins LC.

Breast Cancer Res Treat. 2012 Jan;131(1):159-67. doi: 10.1007/s10549-011-1702-0. Epub 2011 Aug 10.

2.

Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

Marotti JD, Collins LC, Hu R, Tamimi RM.

Mod Pathol. 2010 Feb;23(2):197-204. doi: 10.1038/modpathol.2009.158. Epub 2009 Nov 6.

3.

Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study.

Dawood S, Hu R, Homes MD, Collins LC, Schnitt SJ, Connolly J, Colditz GA, Tamimi RM.

Breast Cancer Res Treat. 2011 Feb;126(1):185-92. doi: 10.1007/s10549-010-1113-7. Epub 2010 Aug 14.

4.

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.

Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC.

Breast Cancer Res. 2008;10(4):R67. doi: 10.1186/bcr2128. Epub 2008 Aug 5.

5.

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC.

JAMA. 2006 Jun 7;295(21):2492-502.

PMID:
16757721
6.

[Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].

Liu H, Fan QH, Zhang ZH, Li X, Yu HP, Liu GZ, Meng FQ.

Zhonghua Bing Li Xue Za Zhi. 2009 Jan;38(1):23-8. Chinese.

PMID:
19489221
7.

Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in infiltrative breast carcinomas in Indian patients.

Munjal K, Ambaye A, Evans MF, Mitchell J, Nandedkar S, Cooper K.

Asian Pac J Cancer Prev. 2009;10(5):773-8.

8.

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM.

Mod Pathol. 2011 Jul;24(7):924-31. doi: 10.1038/modpathol.2011.54. Epub 2011 May 6.

9.

Association between mammographic density and basal-like and luminal A breast cancer subtypes.

Razzaghi H, Troester MA, Gierach GL, Olshan AF, Yankaskas BC, Millikan RC.

Breast Cancer Res. 2013;15(5):R76.

10.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

J Surg Res. 2007 Nov;143(1):109-18.

PMID:
17950079
11.

Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.

Horn J, Alsaker MD, Opdahl S, Engstrøm MJ, Tretli S, Haugen OA, Bofin AM, Vatten LJ, Asvold BO.

Int J Cancer. 2014 Dec 1;135(11):2678-86. doi: 10.1002/ijc.28912. Epub 2014 Apr 29.

PMID:
24752603
12.

Association between common risk factors and molecular subtypes in breast cancer patients.

Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K.

Breast. 2013 Jun;22(3):344-50. doi: 10.1016/j.breast.2012.08.005. Epub 2012 Sep 14.

PMID:
22981738
13.

Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.

Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R, Burkman RT, Strom BL, McDonald JA, Folger SG, Simon MS, Sullivan-Halley J, Press MF, Bernstein L.

BMC Cancer. 2013 May 4;13:225. doi: 10.1186/1471-2407-13-225.

14.

A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.

Wang Y, Yin Q, Yu Q, Zhang J, Liu Z, Wang S, Lv S, Niu Y.

Breast Cancer Res Treat. 2011 Nov;130(2):489-98. doi: 10.1007/s10549-011-1709-6. Epub 2011 Aug 12.

PMID:
21837481
15.

Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.

Izadi P, Mehrdad N, Foruzandeh F, Reza NM.

Asian Pac J Cancer Prev. 2012;13(8):4113-7.

16.

Identification of a basal-like subtype of breast ductal carcinoma in situ.

Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.

Hum Pathol. 2007 Feb;38(2):197-204.

PMID:
17234468
17.

Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.

Guler G, Huebner K, Himmetoglu C, Jimenez RE, Costinean S, Volinia S, Pilarski RT, Hayran M, Shapiro CL.

Cancer. 2009 Feb 15;115(4):899-908. doi: 10.1002/cncr.24103.

18.

Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study.

Al Tamimi DM, Shawarby MA, Ahmed A, Hassan AK, AlOdaini AA.

BMC Cancer. 2010 May 21;10:223. doi: 10.1186/1471-2407-10-223.

19.

Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study.

Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, Cai Q, Lu W, Shu XO.

BMC Cancer. 2011 Jul 12;11:292. doi: 10.1186/1471-2407-11-292.

20.

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO.

Clin Cancer Res. 2008 Mar 1;14(5):1368-76. doi: 10.1158/1078-0432.CCR-07-1658.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk